H3Africa Publications for 2016

  1. Deliberation to Promote Shared Sovereignty in Health Research: Four Questions to Clarify Goals, Methods, and Scope. de Vries J, Munung SN, Tindana P. Am J Bioeth. 2016 Oct;16(10):50-2. doi: 10.1080/15265161.2016.1214326. PMID: 27653401; PMCID: PMC5141257.
  2. Population Stratification and Underrepresentation of Indian Subcontinent Genetic Diversity in the 1000 Genomes Project Dataset. Sengupta D, Choudhury A, Basu A, Ramsay M. Genome Biol Evol. 2016 Dec 31;8(11):3460-3470. doi: 10.1093/gbe/evw244. PMID: 27797945; PMCID: PMC5203783.
  3. High prevalence of individuals with low concentration of fetal hemoglobin in F-cells in sickle cell anemia in Tanzania. Urio F, Lyimo M, Mtatiro SN, Cox SE, Mmbando BP, Makani J. Am J Hematol. 2016 Aug;91(8):E323-4. doi: 10.1002/ajh.24390. Epub 2016 May 11. PMID: 27085091; PMCID: PMC5612395.
  4. Studies of novel variants associated with Hb F in Sardinians and Tanzanians in sickle cell disease patients from Cameroon. Pule GD, Ngo Bitoungui VJ, Chetcha Chemegni B, Kengne AP, Wonkam A. Hemoglobin. 2016 Nov;40(6):377-380. doi: 10.1080/03630269.2016.1251453. Epub 2016 Nov 10. PMID: 27829299.
  5. Burden of Cancers Attributable to Infectious Agents in Nigeria: 2012-2014. Odutola M, Jedy-Agba EE, Dareng EO, Oga EA, Igbinoba F, Otu T, Ezeome E, Hassan R, Adebamowo CA. Front Oncol. 2016 Oct 24;6:216. doi: 10.3389/fonc.2016.00216. PMID: 27822455; PMCID: PMC5075533.
  6. Hydroxyurea down-regulates BCL11A, KLF-1 and MYB through miRNA-mediated actions to induce γ-globin expression: implications for new therapeutic approaches of sickle cell disease. Pule GD, Mowla S, Novitzky N, Wonkam A. Clin Transl Med. 2016 Mar;5(1):15. doi: 10.1186/s40169-016-0092-7. Epub 2016 Apr 7. PMID: 27056246; PMCID: PMC4824700.
  7. Minimum information required for a DMET experiment reporting. Kumuthini J, Mbiyavanga M, Chimusa ER, Pathak J, Somervuo P, Van Schaik RH, Dolzan V, Mizzi C, Kalideen K, Ramesar RS, Macek M, Patrinos GP, Squassina A. Pharmacogenomics. 2016 Sep;17(14):1533-45. doi: 10.2217/pgs-2016-0015. Epub 2016 Aug 22. PMID: 27548815; PMCID: PMC6123892.
  8. Proceedings of a Sickle Cell Disease Ontology workshop – Towards the first comprehensive ontology for Sickle Cell Disease. Mulder N, Nembaware V, Adekile A, Anie KA, Inusa B, Brown B, Campbell A, Chinenere F, Chunda-Liyoka C, Derebail VK, Geard A, Ghedira K, Hamilton CM, Hanchard NA, Haendel M, Huggins W, Ibrahim M, Jupp S, Kamga KK, Knight-Madden J, Lopez-Sall P, Mbiyavanga M, Munube D, Nirenberg D, Nnodu O, Ofori-Acquah SF, Ohene-Frempong K, Opap KB, Panji S, Park M, Pule G, Royal C, Sangeda R, Tayo B, Treadwell M, Tshilolo L, Wonkam A. Appl Transl Genom. 2016 Mar 15;9:23-9. doi: 10.1016/j.atg.2016.03.005. PMID: 27354937; PMCID: PMC4911424.
  9. Controlling cardiovascular diseases in low and middle income countries by placing proof in pragmatism. Owolabi M, Miranda JJ, Yaria J, Ovbiagele B. BMJ Glob Health. 2016 Oct 5;1(3):e000105. doi: 10.1136/bmjgh-2016-000105. PMID: 27840737; PMCID: PMC5103314.
  10. Julie Makani: at the cutting edge of sickle-cell disease. Watts G. Lancet. 2016 Jul 2;388(10039):21. doi: 10.1016/S0140-6736(16)30941-2. PMID: 27397782.
  11. The burden of HPV associated cancers in two regions in Nigeria 2012-2014. Jedy-Agba EE, Dareng EO, Adebamowo SN, Odutola M, Oga EA, Igbinoba F, Otu T, Ezeome E, Bray F, Hassan R, Adebamowo CA. Cancer Epidemiol. 2016 Dec;45:91-97. doi: 10.1016/j.canep.2016.10.008. Epub 2016 Oct 22. Erratum in: Cancer Epidemiol. 2018 Oct;56:171. PMID: 27780076; PMCID: PMC5124511.
  12. Paucity of HPV-Related Head and Neck Cancers (HNC) in Nigeria. Oga EA, Schumaker LM, Alabi BS, Obaseki D, Umana A, Bassey IA, Ebughe G, Oluwole O, Akeredolu T, Adebamowo SN, Dakum P, Cullen K, Adebamowo CA. PLoS One. 2016 Apr 6;11(4):e0152828. doi: 10.1371/journal.pone.0152828. PMID: 27050815; PMCID: PMC4822856.
  13. Evolving perspectives on broad consent for genomics research and biobanking in Africa. Report of the Second H3Africa Ethics Consultation Meeting, 11 May 2015. de Vries J, Littler K, Matimba A, McCurdy S, Ouwe Missi Oukem-Boyer O, Seeley J, Tindana P. Glob Health Epidemiol Genom. 2016 Jul 25;1:e13. doi: 10.1017/gheg.2016.5. PMID: 29868205; PMCID: PMC5870421.
  14. Rates and risk factors of hypertension in adolescents and adults with sickle cell anaemia in Tanzania: 10 years’ experience. Makubi A, Mmbando BP, Novelli EM, Lwakatare J, Soka D, Marik H, Tibarazwa K, Ngaeje M, Newton CR, Gladwin MT, Makani J. Br J Haematol. 2017 Jun;177(6):930-937. doi: 10.1111/bjh.14330. Epub 2016 Sep 21. PMID: 27650269; PMCID: PMC5612392.
  15. An Expert Review of Pharmacogenomics of Sickle Cell Disease Therapeutics: Not Yet Ready for Global Precision Medicine. Mnika K, Pule GD, Dandara C, Wonkam A. OMICS. 2016 Oct;20(10):565-574. doi: 10.1089/omi.2016.0105. Epub 2016 Sep 16. PMID: 27636225; PMCID: PMC5067801.
  16. Respiratory microbes present in the nasopharynx of children hospitalised with suspected pulmonary tuberculosis in Cape Town, South Africa. Dube FS, Kaba M, Robberts FJ, Ah Tow L, Lubbe S, Zar HJ, Nicol MP. BMC Infect Dis. 2016 Oct 24;16(1):597. doi: 10.1186/s12879-016-1934-z. PMID: 27776489; PMCID: PMC5075757.
  17. Genetics of Sickle Cell-Associated Cardiovascular Disease: An Expert Review with Lessons Learned in Africa. Geard A, Pule GD, Chelo D, Bitoungui VJ, Wonkam A. OMICS. 2016 Oct;20(10):581-592. doi: 10.1089/omi.2016.0125. PMID: 27726639; PMCID: PMC5067873.
  18. Gaps in Hypertension Guidelines in Low- and Middle-Income Versus High-Income Countries: A Systematic Review. Owolabi M, Olowoyo P, Miranda JJ, Akinyemi R, Feng W, Yaria J, Makanjuola T, Yaya S, Kaczorowski J, Thabane L, Van Olmen J, Mathur P, Chow C, Kengne A, Saulson R, Thrift AG, Joshi R, Bloomfield GS, Gebregziabher M, Parker G, Agyemang C, Modesti PA, Norris S, Ogunjimi L, Farombi T, Melikam ES, Uvere E, Salako B, Ovbiagele B; COUNCIL Initiative. Hypertension. 2016 Dec;68(6):1328-1337. doi: 10.1161/HYPERTENSIONAHA.116.08290. Epub 2016 Oct 3. PMID: 27698059; PMCID: PMC5159303.
  19. A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics. Mizzi C, Dalabira E, Kumuthini J, Dzimiri N, Balogh I, Başak N, Böhm R, Borg J, Borgiani P, Bozina N, Bruckmueller H, Burzynska B, Carracedo A, Cascorbi I, Deltas C, Dolzan V, Fenech A, Grech G, Kasiulevicius V, Kádaši Ľ, Kučinskas V, Khusnutdinova E, Loukas YL, Macek M Jr, Makukh H, Mathijssen R, Mitropoulos K, Mitropoulou C, Novelli G, Papantoni I, Pavlovic S, Saglio G, Setric J, Stojiljkovic M, Stubbs AP, Squassina A, Torres M, Turnovec M, van Schaik RH, Voskarides K, Wakil SM, Werk A, Del Zompo M, Zukic B, Katsila T, Lee MT, Motsinger-Rief A, Mc Leod HL, van der Spek PJ, Patrinos GP. PLoS One. 2016 Sep 16;11(9):e0162866. doi: 10.1371/journal.pone.0162866. Erratum in: PLoS One. 2017 Feb 16;12 (2):e0172595. PMID: 27636550; PMCID: PMC5026342.
  20. H3Africa multi-centre study of the prevalence and environmental and genetic determinants of type 2 diabetes in sub-Saharan Africa: study protocol. Ekoru K, Young EH, Adebamowo C, Balde N, Hennig BJ, Kaleebu P, Kapiga S, Levitt NS, Mayige M, Mbanya JC, McCarthy MI, Nyan O, Nyirenda M, Oli J, Ramaiya K, Smeeth L, Sobngwi E, Rotimi CN, Sandhu MS, Motala AA. Glob Health Epidemiol Genom. 2016 Mar 8;1:e5. doi: 10.1017/gheg.2015.6. PMID: 29276615; PMCID: PMC5732581.
  21. H3Africa AWI-Gen Collaborative Centre: a resource to study the interplay between genomic and environmental risk factors for cardiometabolic diseases in four sub-Saharan African countries. Ramsay M, Crowther N, Tambo E, Agongo G, Baloyi V, Dikotope S, Gómez-Olivé X, Jaff N, Sorgho H, Wagner R, Khayeka-Wandabwa C, Choudhury A, Hazelhurst S, Kahn K, Lombard Z, Mukomana F, Soo C, Soodyall H, Wade A, Afolabi S, Agorinya I, Amenga-Etego L, Ali SA, Bognini JD, Boua RP, Debpuur C, Diallo S, Fato E, Kazienga A, Konkobo SZ, Kouraogo PM, Mashinya F, Micklesfield L, Nakanabo-Diallo S, Njamwea B, Nonterah E, Ouedraogo S, Pillay V, Somande AM, Tindana P, Twine R, Alberts M, Kyobutungi C, Norris SA, Oduro AR, Tinto H, Tollman S, Sankoh O. Glob Health Epidemiol Genom. 2016 Nov 22;1:e20. doi: 10.1017/gheg.2016.17. PMID: 29276616; PMCID: PMC5732578.
  22. Analysis of non-peptidic compounds as potential malarial inhibitors against Plasmodial cysteine proteases via integrated virtual screening workflow. Musyoka TM, Kanzi AM, Lobb KA, Tastan Bishop Ö.J Biomol Struct Dyn. 2016 Oct;34(10):2084-101. doi: 10.1080/07391102.2015.1108231. Epub 2016 Jan 28. PMID: 26471975
  23. Ebola Virus Epidemiology and Evolution in Nigeria. Folarin OA, Ehichioya D, Schaffner SF, Winnicki SM, Wohl S, Eromon P, West KL, Gladden-Young A, Oyejide NE, Matranga CB, Deme AB, James A, Tomkins-Tinch C, Onyewurunwa K, Ladner JT, Palacios G, Nosamiefan I, Andersen KG, Omilabu S, Park DJ, Yozwiak NL, Nasidi A, Garry RF, Tomori O, Sabeti PC, Happi CT. J Infect Dis. 2016 Jul 4. pii: jiw190. [Epub ahead of print] PMID: 27377746
  24. Genomic approaches to the burden of kidney disease in Sub-Saharan Africa: the Human Heredity and Health in Africa (H3Africa) Kidney Disease Research Network. Osafo C, Raji YR, Olanrewaju T, Mamven M, Arogundade F, Ajayi S, Ulasi I, Salako B, Plange-Rhule J, Mengistu Y, Mc’Ligeyo SO, Moturi G, Winkler CA, Moxey-Mims MM, Rasooly RS, Kimmel P, Adu D, Ojo A, Parekh RS; H3Africa Kidney Disease Research Network.
    Kidney Int. 2016 Jul;90(1):2-5. doi: 10.1016/j.kint.2015.12.059. No abstract available. PMID: 27312436
  25. Neurogenomics in Africa: Perspectives, progress, possibilities and priorities. Akinyemi RO, Owolabi MO, Oyeniyi T, Ovbiagele B, Arnett DK, Tiwari HK, Walker R, Ogunniyi A, Kalaria RN; SIREN group of H3Africa Consortium. J Neurol Sci. 2016 Jul 15;366:213-23. doi: 10.1016/j.jns.2016.05.006. Epub 2016 May 6. Review. PMID: 27288810
  26. Short term stroke outcome is worse among indiv1iduals with sickle cell trait. Olowoyo P, Owolabi MO, Fawale B, Ogunniyi A.eNeurologicalSci. 2016 Jun;3:64-68. PMID: 27355086
  27.  Validation of the 8-item questionnaire for verifying stroke free status with and without pictograms in three West African languages. Sarfo FS, Gebregziabher M, Ovbiagele B, Akinyemi R, Owolabi L, Obiako R, Armstrong K, Arulogun O, Akpalu A, Melikam S, Saulson R, Jenkins C, Owolabi M; SIREN. eNeurologicalSci. 2016 Jun;3:75-79. PMID: 27148595
  28. Profile of neurological disorders in an adult neurology clinic in Kumasi, Ghana. Sarfo FS, Akassi J, Badu E, Okorozo A, Ovbiagele B, Akpalu A. eNeurologicalSci. 2016 Jun;3:69-74. PMID: 27110596
  29.  Carotid IMT is more associated with stroke than risk calculators. Owolabi MO, Akpa OM, Agunloye AM. Acta Neurol Scand. 2016 Jun;133(6):442-50. doi: 10.1111/ane.12482. Epub 2015 Sep 10. PMID: 27045896
  30. Recurrence of cervical intraepithelial lesions after thermo-coagulation in HIV-positive and HIV-negative Nigerian women. Oga EA, Brown JP, Brown C, Dareng E, Adekanmbi V, Odutola M, Olaniyan O, Offiong R, Obende K, Adewole AS, Peter A, Dakum P, Adebamowo C. BMC Womens Health. 2016 May 11;16:25. doi: 10.1186/s12905-016-0304-8.PMID: 27169666
  31. Stroke patients and their attitudes toward mHealth monitoring to support blood pressure control and medication adherence. Jenkins C, Burkett NS, Ovbiagele B, Mueller M, Patel S, Brunner-Jackson B, Saulson R, Treiber F. Mhealth. 2016 May;2. pii: 24. Epub 2016 Jun 3.
    PMID: 27347490
  32. Aetiology of childhood pneumonia in a well vaccinated South African birth cohort: a nested case-control study of the Drakenstein Child Health Study. Zar HJ, Barnett W, Stadler A, Gardner-Lubbe S, Myer L, Nicol MP.Lancet Respir Med. 2016 Apr 21. pii: S2213-2600(16)00096-5. doi: 10.1016/S2213-2600(16)00096-5. [Epub ahead of print] PMID: 27117547
  33. Paucity of HPV-Related Head and Neck Cancers (HNC) in Nigeria. Oga EA, Schumaker LM, Alabi BS, Obaseki D, Umana A, Bassey IA, Ebughe G, Oluwole O, Akeredolu T, Adebamowo SN, Dakum P, Cullen K, Adebamowo CA. PLoS One. 2016 Apr 6;11(4):e0152828. doi: 10.1371/journal.pone.0152828. eCollection 2016.PMID: 27050815
  34. African partnerships through the H3Africa Consortium bring a genomic dimension to longitudinal population studies on the continent. Ramsay M, Sankoh O; as members of the AWI-Gen study and the H3Africa Consortium. Int J Epidemiol. 2016 Apr;45(2):305-8. doi: 10.1093/ije/dyv187. Epub 2015 Dec 10. No abstract available. PMID: 26659658
  35. Stroke Investigative Research and Education Network: Community Engagement and Outreach Within Phenomics Core. Jenkins C, Arulogun OS, Singh A, Mande AT, Ajayi E, Benedict CT, Ovbiagele B, Lackland DT, Sarfo FS, Akinyemi R, Akpalu A, Obiako R, Melikam ES, Laryea R, Shidali V, Sagoe K, Ibinaiye P, Fakunle AG, Owolabi LF, Owolabi MO; SIREN Team. Health Educ Behav. 2016 Apr;43(1 Suppl):82S-92S. doi: 10.1177/1090198116634082. Erratum in: Health Educ Behav. 2016 Aug;43(4):480.
    PMID: 27037152
  36. Genetics and genomic medicine in Mali: challenges and future perspectives.Landouré G, Samassékou O, Traoré M, Meilleur KG, Guinto CO, Burnett BG, Sumner CJ, Fischbeck KH. Mol Genet Genomic Med. 2016 Mar 17;4(2):126-34. doi: 10.1002/mgg3.212. eCollection 2016 Mar.PMID: 27066513
  37. Structure Based Docking and Molecular Dynamic Studies of Plasmodial Cysteine Proteases against a South African Natural Compound and its Analogs. Musyoka TM, Kanzi AM, Lobb KA, Tastan Bishop Ö.Sci Rep. 2016 Mar 31;6:23690. doi: 10.1038/srep23690.PMID: 27030511
  38. Building a Platform to Enable NCD Research to Address Population Health in Africa: CVD Working Group Discussion at the Sixth H3Africa Consortium Meeting in Zambia.Peprah E, Wiley K, Troyer J, Adebamowo SN, Adu D, Mayosi BM, Ramsay M, Motala AA, Adebamowo C, Ovbiagele B, Owolabi M; H3Africa Cardiovascular Diseases Working Group and as members of the H3Africa Consortium. Glob Heart. 2016 Mar;11(1):165-70. doi: 10.1016/j.gheart.2015.11.002. No abstract available.PMID: 27102038
  39. NetCapDB: measuring bioinformatics capacity development in Africa. Bendou H, Domelevo Entfellner JB, van Heusden P, Gamieldien J, Tiffin N; H3ABioNet Consortium, as members of the H3Africa Consortium. BMC Res Notes. 2016 Mar 5;9(1):144. doi: 10.1186/s13104-016-1950-5.PMID: 26945860
  40. Obtaining informed consent for genomics research in Africa: analysis of H3Africa consent documents. Munung NS, Marshall P, Campbell M, Littler K, Masiye F, Ouwe-Missi-Oukem-Boyer O, Seeley J, Stein DJ, Tindana P, de Vries J. J Med Ethics. 2016 Feb;42(2):132-7. doi: 10.1136/medethics-2015-102796. Epub 2015 Dec 7. PMID: 26644426
  41. ancGWAS: a post genome-wide association study method for interaction, pathway and ancestry analysis in homogeneous and admixed populations. Chimusa ER, Mbiyavanga M, Mazandu GK, Mulder NJ.Bioinformatics. 2016 Feb 15;32(4):549-56. doi: 0.1093/bioinformatics/btv619. Epub 2015 Oct 27. PMID: 26508762
  42.  A-DaGO-Fun: an adaptable Gene Ontology semantic similarity-based functional analysis tool. Mazandu GK, Chimusa ER, Mbiyavanga M, Mulder NJ. Bioinformatics. 2016 Feb 1;32(3):477-9. doi: 10.1093/bioinformatics/btv590. Epub 2015 Oct 17.PMID: 26476781
  43. H3ABioNet, a sustainable pan-African bioinformatics network for human heredity and health in Africa. Mulder NJ, Adebiyi E, Alami R, Benkahla A, Brandful J, Doumbia S, Everett D, Fadlelmola FM, Gaboun F, Gaseitsiwe S, Ghazal H, Hazelhurst S, Hide W, Ibrahimi A, Jaufeerally Fakim Y, Jongeneel CV, Joubert F, Kassim S, Kayondo J, Kumuthini J, Lyantagaye S, Makani J, Mansour Alzohairy A, Masiga D, Moussa A, Nash O, Ouwe Missi Oukem-Boyer O, Owusu-Dabo E, Panji S, Patterton H, Radouani F, Sadki K, Seghrouchni F, Tastan Bishop Ö, Tiffin N, Ulenga N; H3ABioNet Consortium. Genome Res. 2016 Feb;26(2):271-7. doi: 10.1101/gr.196295.115. Epub 2015 Dec 1.PMID: 26627985
  44.  The Development of Computational Biology in South Africa: Successes Achieved and Lessons Learnt. Mulder NJ, Christoffels A, de Oliveira T, Gamieldien J, Hazelhurst S, Joubert F, Kumuthini J, Pillay CS, Snoep JL, Tastan Bishop Ö, Tiffin N. PLoS Comput Biol. 2016 Feb 4;12(2):e1004395. doi: 10.1371/journal.pcbi.1004395. eCollection 2016 Feb.PMID: 26845152
  45. Obtaining informed consent for genomics research in Africa: analysis of H3Africa consent documents. Munung NS, Marshall P, Campbell M, Littler K, Masiye F, Ouwe-Missi-Oukem-Boyer O, Seeley J, Stein DJ, Tindana P, de Vries J. J Med Ethics. 2016 Feb;42(2):132-7. doi: 10.1136/medethics-2015-102796. Epub 2015 Dec 7.PMID: 26644426
  46. Multilingual Validation of the Questionnaire for Verifying Stroke-Free Status in West Africa.  Sarfo F, Gebregziabher M, Ovbiagele B, Akinyemi R, Owolabi L, Obiako R, Akpa O, Armstrong K, Akpalu A, Adamu S, Obese V, Boa-Antwi N, Appiah L, Arulogun O, Mensah Y, Adeoye A, Tosin A, Adeleye O, Tabi-Ajayi E, Phillip I, Sani A, Isah S, Tabari N, Mande A, Agunloye A, Ogbole G, Akinyemi J, Laryea R, Melikam S, Uvere E, Adekunle G, Kehinde S, Azuh P, Dambatta A, Ishaq N, Saulson R, Arnett D, Tiwari H, Jenkins C, Lackland D, Owolabi M; Stroke Investigative Research Educational Networks. Stroke. 2016 Jan;47(1):167-72. doi: 10.1161/STROKEAHA.115.010374. Epub 2015 Nov 17. PMID: 26578660
  47. Qualitative study of barriers to cervical cancer screening among Nigerian women. Isa Modibbo F, Dareng E, Bamisaye P, Jedy-Agba E, Adewole A, Oyeneyin L, Olaniyan O, Adebamowo C. BMJ Open. 2016 Jan 11;6(1):e008533. doi: 10.1136/bmjopen-2015-008533.PMID: 26754174
  48. Prevalent high-risk HPV infection and vaginal microbiota in Nigerian women. Dareng EO, Ma B, Famooto AO, Akarolo-Anthony SN, Offiong RA, Olaniyan O, Dakum PS, Wheeler CM, Fadrosh D, Yang H, Gajer P, Brotman RM, Ravel J, Adebamowo CA. Epidemiol Infect. 2016 Jan;144(1):123-37. doi: 10.1017/S0950268815000965. Epub 2015 Jun 11.PMID: 26062721